Type |
Details |
Score |
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1797221 |
Pattern: |
Regionally restricted |
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10877 |
|
Specimen Label: |
GUDMAP:10877 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Present |
Sex: |
Female |
Emaps: |
EMAPS:2894021 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10878 |
|
Specimen Label: |
GUDMAP:10878 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Ambiguous |
Sex: |
Male |
Emaps: |
EMAPS:2914321 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10877 |
Note: |
possible expression which may be background |
Specimen Label: |
GUDMAP:10877 |
|
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1797321 |
|
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10877 |
|
Specimen Label: |
GUDMAP:10877 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Ambiguous |
Sex: |
Female |
Emaps: |
EMAPS:2892421 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10878 |
Note: |
possible expression but most likely to be background |
Specimen Label: |
GUDMAP:10878 |
|
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689419 |
|
Stage: |
TS19 |
Assay Id: |
MGI:6189893 |
Age: |
embryonic day 11.5 |
|
|
Specimen Label: |
Table S2 - E11.5 - C4b |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689421 |
|
Stage: |
TS21 |
Assay Id: |
MGI:6189893 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
Table S2 - E13.5 - C4b |
Detected: |
false |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689424 |
|
Stage: |
TS24 |
Assay Id: |
MGI:6189893 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
Table S2 - E15.5 - C4b |
Detected: |
false |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689426 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6189893 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
Table S2 - E18.5 - C4b |
Detected: |
false |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6189893 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - C4b |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6189893 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - C4b |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6168808 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:6189893 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - C4b |
Detected: |
true |
Specimen Num: |
7 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7451095 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2023-04-06 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689428 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:7451210 |
Age: |
postnatal |
Image: |
S14a |
|
Specimen Label: |
S14a |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Present |
Sex: |
Female |
Emaps: |
EMAPS:1796221 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10878 |
|
Specimen Label: |
GUDMAP:10878 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4846031 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:3046021 |
|
Stage: |
TS21 |
Assay Id: |
MGI:5540842 |
Age: |
embryonic day 13.5 |
Image: |
GUDMAP:10877 |
|
Specimen Label: |
GUDMAP:10877 |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
Publication |
First Author: |
WHO-IUIS Nomenclature Sub-Committee |
Year: |
1993 |
Journal: |
Eur J Immunogenet |
Title: |
Revised nomenclature for human complement component C4. |
Volume: |
20 |
|
Pages: |
301-305 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cheng J |
Year: |
1993 |
Journal: |
Biochem J |
Title: |
cDNA cloning and characterization of the protein encoded by RD, a gene located in the class III region of the human major histocompatibility complex. |
Volume: |
294 ( Pt 2) |
|
Pages: |
589-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Laich A |
Year: |
2001 |
Journal: |
Biochim Biophys Acta |
Title: |
Complement C4bC2 complex formation: an investigation by surface plasmon resonance. |
Volume: |
1544 |
Issue: |
1-2 |
Pages: |
96-112 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rawal N |
Year: |
1998 |
Journal: |
J Biol Chem |
Title: |
C5 convertase of the alternative pathway of complement. Kinetic analysis of the free and surface-bound forms of the enzyme. |
Volume: |
273 |
Issue: |
27 |
Pages: |
16828-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kam CM |
Year: |
1987 |
Journal: |
J Biol Chem |
Title: |
Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates. |
Volume: |
262 |
Issue: |
8 |
Pages: |
3444-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
The Jackson Laboratory Backcross DNA Panel Mapping Resource |
Year: |
1999 |
Journal: |
Database Release |
Title: |
JAX BSS Panel Mapping Data |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Gennaro R |
Year: |
1986 |
Journal: |
Eur J Biochem |
Title: |
C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other structural studies. |
Volume: |
155 |
Issue: |
1 |
Pages: |
77-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fritzinger DC |
Year: |
1992 |
Journal: |
J Immunol |
Title: |
Primary structure of cobra complement component C3. |
Volume: |
149 |
Issue: |
11 |
Pages: |
3554-62 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Homologous_superfamily |
Description: |
Complement components C3, C4 and C5 are large glycoproteins that have important functions in the immune response and host defence []. They have a wide variety of biological activities and are proteolytically activated by cleavage at a specific site, forming a- and b-fragments []. A-fragments form distinct structural domains of approximately 76 amino acids, coded for by a single exon within the complement protein gene. The C3a, C4a and C5a components are referred to as anaphylatoxins [, ]: they cause smooth muscle contraction, histamine release from mast cells, and enhanced vascular permeability []. They also mediate chemotaxis, inflammation, and generation of cytotoxic oxygen radicals []. The proteins are highly hydrophilic, with a mainly α-helical structure held together by 3 disulphide bridges []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Pan TC |
Year: |
1993 |
Journal: |
J Cell Biol |
Title: |
Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding. |
Volume: |
123 |
Issue: |
5 |
Pages: |
1269-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Argraves WS |
Year: |
1990 |
Journal: |
J Cell Biol |
Title: |
Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. |
Volume: |
111 |
Issue: |
6 Pt 2 |
Pages: |
3155-64 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents C3a, C4a and C5a anaphylatoxins, which are protein fragments generated enzymatically in serum during activation of complement molecules C3, C4, and C5. They induce smooth muscle contraction. These fragments are homologous to a three-fold repeat in fibulins.Complement components C3, C4 and C5 are large glycoproteins that have important functions in the immune response and host defence []. They have a wide variety of biological activities and are proteolytically activated by cleavage at a specific site, forming a- and b-fragments []. A-fragments form distinct structural domains of approximately 76 amino acids, coded for by a single exon within the complement protein gene. The C3a, C4a and C5a components are referred to as anaphylatoxins [, ]: they cause smooth muscle contraction, histamine release from mast cells, and enhanced vascular permeability []. They also mediate chemotaxis, inflammation, and generation of cytotoxic oxygen radicals []. The proteins are highly hydrophilic, with a mainly α-helical structure held together by 3 disulphide bridges [].Fibulins are secreted glycoproteins that become incorporated into a fibrillar extracellular matrix when expressed by cultured cells or added exogenously to cell monolayers [, ]. The five known members of the family share an elongated structure and many calcium-binding sites, owing to the presence of tandem arrays of epidermal growth factor-like domains. They have overlapping binding sites for several basement-membrane proteins, tropoelastin, fibrillin, fibronectin and proteoglycans, and they participate in diverse supramolecular structures. The amino-terminal domain I of fibulin consists of three anaphylatoxin-like (AT) modules, each approximately 40 residues long and containing four or six cysteines. The structure of an AT module was determined for the complement-derived anaphylatoxin C3a, and was found to be a compact α-helical fold that is stabilised by three disulphide bridges in the pattern Cys1-4, Cys2-5 and Cys3-6 (where Cys is cysteine). The bulk of the remaining portion of the fibulin molecule is a series of nine EGF-like repeats []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
195
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Tornetta MA |
Year: |
1997 |
Journal: |
J Immunol |
Title: |
The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression. |
Volume: |
158 |
Issue: |
11 |
Pages: |
5277-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hsu MH |
Year: |
1997 |
Journal: |
Immunogenetics |
Title: |
Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. |
Volume: |
47 |
Issue: |
1 |
Pages: |
64-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Honczarenko M |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. |
Volume: |
175 |
Issue: |
6 |
Pages: |
3698-706 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mao C |
Year: |
2004 |
Journal: |
Immunity |
Title: |
T cell-independent somatic hypermutation in murine B cells with an immature phenotype. |
Volume: |
20 |
Issue: |
2 |
Pages: |
133-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nelson KC |
Year: |
2006 |
Journal: |
J Clin Invest |
Title: |
Role of different pathways of the complement cascade in experimental bullous pemphigoid. |
Volume: |
116 |
Issue: |
11 |
Pages: |
2892-900 |
|
•
•
•
•
•
|
Publication |
First Author: |
Banda NK |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. |
Volume: |
177 |
Issue: |
3 |
Pages: |
1904-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taube C |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. |
Volume: |
103 |
Issue: |
21 |
Pages: |
8084-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Solomon S |
Year: |
2002 |
Journal: |
Eur J Immunol |
Title: |
Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). |
Volume: |
32 |
Issue: |
3 |
Pages: |
644-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bottermann M |
Year: |
2019 |
Journal: |
Cell Host Microbe |
Title: |
Complement C4 Prevents Viral Infection through Capsid Inactivation. |
Volume: |
25 |
Issue: |
4 |
Pages: |
617-629.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Asgari E |
Year: |
2014 |
Journal: |
FASEB J |
Title: |
Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4. |
Volume: |
28 |
Issue: |
9 |
Pages: |
3996-4003 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fournier LA |
Year: |
2024 |
Journal: |
iScience |
Title: |
Overexpression of the schizophrenia risk gene C4 in PV cells drives sex-dependent behavioral deficits and circuit dysfunction. |
Volume: |
27 |
Issue: |
9 |
Pages: |
110800 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meo T |
Year: |
1977 |
Journal: |
Science |
Title: |
Glyoxalase I polymorphism in the mouse: a new genetic marker linked to H-2. |
Volume: |
198 |
Issue: |
4314 |
Pages: |
311-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Natsuume-Sakai S |
Year: |
1983 |
Journal: |
Immunogenetics |
Title: |
Structural polymorphism of murine factor B controlled by a locus closely linked to the H-2 complex and demonstration of multiple alleles. |
Volume: |
18 |
Issue: |
2 |
Pages: |
117-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tosi M |
Year: |
1985 |
Journal: |
Immunol Rev |
Title: |
Duplications of complement and non-complement genes of the H-2S region: evolutionary aspects of the C4 isotypes and molecular analysis of their expression variants. |
Volume: |
87 |
|
Pages: |
151-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gullstrand B |
Year: |
2009 |
Journal: |
Clin Exp Immunol |
Title: |
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. |
Volume: |
156 |
Issue: |
2 |
Pages: |
303-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wallis R |
Year: |
2010 |
Journal: |
Immunobiology |
Title: |
Paths reunited: Initiation of the classical and lectin pathways of complement activation. |
Volume: |
215 |
Issue: |
1 |
Pages: |
1-11 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
348
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
333
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
356
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
351
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
352
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
352
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
348
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Complement components C3, C4 and C5 are large glycoproteins that have important functions in the immune response and host defence []. They have a wide variety of biological activities and are proteolytically activated by cleavage at a specific site, forming a- and b-fragments []. A-fragments form distinct structural domains of approximately 76 amino acids, coded for by a single exon within the complement protein gene. The C3a, C4a and C5a components are referred to as anaphylatoxins [, ]: they cause smooth muscle contraction, histamine release from mast cells, and enhanced vascular permeability []; they also mediate chemotaxis, inflammation, and generation of cytotoxic oxygen radicals []. The proteins are highly hydrophilic, with a mainly α-helical structure held together by 3 disulphide bridges [].Some of the proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Complement C4 belongs to the Chido/Rodgers blood group system and is associated with Ch1 to Ch6, WH, Rg1 and Rg2 antigens. |
|
•
•
•
•
•
|
Publication |
First Author: |
Cazzaniga G |
Year: |
1994 |
Journal: |
Genomics |
Title: |
Chromosomal mapping, isolation, and characterization of the mouse xanthine dehydrogenase gene. |
Volume: |
23 |
Issue: |
2 |
Pages: |
390-402 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suber F |
Year: |
2007 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Innate response to self-antigen significantly exacerbates burn wound depth. |
Volume: |
104 |
Issue: |
10 |
Pages: |
3973-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wessels MR |
Year: |
1995 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. |
Volume: |
92 |
Issue: |
25 |
Pages: |
11490-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Springall T |
Year: |
2001 |
Journal: |
Nat Med |
Title: |
Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. |
Volume: |
7 |
Issue: |
7 |
Pages: |
801-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schwaeble WJ |
Year: |
2011 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. |
Volume: |
108 |
Issue: |
18 |
Pages: |
7523-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tüzün E |
Year: |
2003 |
Journal: |
J Immunol |
Title: |
Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. |
Volume: |
171 |
Issue: |
7 |
Pages: |
3847-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manderson AP |
Year: |
2001 |
Journal: |
J Exp Med |
Title: |
Continual low-level activation of the classical complement pathway. |
Volume: |
194 |
Issue: |
6 |
Pages: |
747-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Farrar CA |
Year: |
2016 |
Journal: |
J Clin Invest |
Title: |
Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. |
Volume: |
126 |
Issue: |
5 |
Pages: |
1911-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fischer MB |
Year: |
1996 |
Journal: |
J Immunol |
Title: |
Regulation of the B cell response to T-dependent antigens by classical pathway complement. |
Volume: |
157 |
Issue: |
2 |
Pages: |
549-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cresci GA |
Year: |
2015 |
Journal: |
Mol Immunol |
Title: |
Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CClâ‚„-induced injury. |
Volume: |
64 |
Issue: |
1 |
Pages: |
9-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hébert MJ |
Year: |
1998 |
Journal: |
Nephrol Dial Transplant |
Title: |
Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. |
Volume: |
13 |
Issue: |
11 |
Pages: |
2799-803 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fischer MB |
Year: |
1997 |
Journal: |
J Immunol |
Title: |
Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. |
Volume: |
159 |
Issue: |
2 |
Pages: |
976-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Quigg RJ |
Year: |
1998 |
Journal: |
Kidney Int |
Title: |
Immune complex glomerulonephritis in C4- and C3-deficient mice. |
Volume: |
53 |
Issue: |
2 |
Pages: |
320-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Natsuume-Sakai S |
Year: |
1978 |
Journal: |
J Immunol |
Title: |
Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17. |
Volume: |
121 |
Issue: |
2 |
Pages: |
491-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sackstein R |
Year: |
1984 |
Journal: |
Immunogenetics |
Title: |
Subdivision of the S region of the mouse major histocompatibility complex by identification of genomic polymorphisms of the class III genes. |
Volume: |
20 |
Issue: |
3 |
Pages: |
321-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ebanks RO |
Year: |
1996 |
Journal: |
Mol Immunol |
Title: |
Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. |
Volume: |
33 |
Issue: |
3 |
Pages: |
297-309 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cortese Hassett AL |
Year: |
1989 |
Journal: |
Transplant Proc |
Title: |
Mapping and sequencing analysis of the rat MHC. |
Volume: |
21 |
Issue: |
2 |
Pages: |
3244-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mershon-Shier KL |
Year: |
2011 |
Journal: |
Mol Immunol |
Title: |
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways. |
Volume: |
48 |
Issue: |
15-16 |
Pages: |
2009-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Douglas TC |
Year: |
1979 |
Journal: |
Mouse News Lett |
Title: |
Chromosome 17 |
Volume: |
60 |
|
Pages: |
58 |
|
•
•
•
•
•
|
Publication |
First Author: |
White PC |
Year: |
1985 |
Journal: |
Immunol Rev |
Title: |
Adrenal 21-hydroxylase cytochrome P-450 genes within the MHC class III region. |
Volume: |
87 |
|
Pages: |
123-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kawaguchi H |
Year: |
1992 |
Journal: |
Hum Immunol |
Title: |
Organization of C4 and CYP21 loci in gorilla and orangutan. |
Volume: |
33 |
Issue: |
3 |
Pages: |
153-62 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
535
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
674
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
535
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
535
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
535
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
200
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
674
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
62
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
535
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Timpl R |
Year: |
2003 |
Journal: |
Nat Rev Mol Cell Biol |
Title: |
Fibulins: a versatile family of extracellular matrix proteins. |
Volume: |
4 |
Issue: |
6 |
Pages: |
479-89 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsushita M |
Year: |
2000 |
Journal: |
J Immunol |
Title: |
Proteolytic activities of two types of mannose-binding lectin-associated serine protease. |
Volume: |
165 |
Issue: |
5 |
Pages: |
2637-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kerr MA |
Year: |
1980 |
Journal: |
Biochem J |
Title: |
The human complement system: assembly of the classical pathway C3 convertase. |
Volume: |
189 |
Issue: |
1 |
Pages: |
173-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Heimbach L |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid. |
Volume: |
286 |
Issue: |
17 |
Pages: |
15003-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Z |
Year: |
2000 |
Journal: |
J Exp Med |
Title: |
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. |
Volume: |
192 |
Issue: |
9 |
Pages: |
1339-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gupta VA |
Year: |
2008 |
Journal: |
J Exp Med |
Title: |
B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency. |
Volume: |
205 |
Issue: |
12 |
Pages: |
2755-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Einav S |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
Complement C4 is protective for lupus disease independent of C3. |
Volume: |
168 |
Issue: |
3 |
Pages: |
1036-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Renner B |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. |
Volume: |
185 |
Issue: |
7 |
Pages: |
4393-400 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gadjeva M |
Year: |
2002 |
Journal: |
J Immunol |
Title: |
Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. |
Volume: |
169 |
Issue: |
10 |
Pages: |
5489-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Williams JP |
Year: |
1999 |
Journal: |
J Appl Physiol (1985) |
Title: |
Intestinal reperfusion injury is mediated by IgM and complement. |
Volume: |
86 |
Issue: |
3 |
Pages: |
938-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou W |
Year: |
2006 |
Journal: |
Blood |
Title: |
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. |
Volume: |
107 |
Issue: |
6 |
Pages: |
2461-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mueller-Ortiz SL |
Year: |
2004 |
Journal: |
Infect Immun |
Title: |
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. |
Volume: |
72 |
Issue: |
5 |
Pages: |
2899-906 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ramos TN |
Year: |
2012 |
Journal: |
J Biol Chem |
Title: |
The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. |
Volume: |
287 |
Issue: |
29 |
Pages: |
24734-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gralinski LE |
Year: |
2018 |
Journal: |
mBio |
Title: |
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. |
Volume: |
9 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Clark A |
Year: |
2008 |
Journal: |
Mol Immunol |
Title: |
Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. |
Volume: |
45 |
Issue: |
11 |
Pages: |
3125-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Prodeus AP |
Year: |
1997 |
Journal: |
Nature |
Title: |
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. |
Volume: |
390 |
Issue: |
6656 |
Pages: |
172-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Katschke KJ Jr |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy. |
Volume: |
8 |
Issue: |
1 |
Pages: |
7348 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taylor PR |
Year: |
2000 |
Journal: |
J Exp Med |
Title: |
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. |
Volume: |
192 |
Issue: |
3 |
Pages: |
359-66 |
|
•
•
•
•
•
|